RCLY vs. TMED
RCLY (Reckoner BBB-B CLO Annual ETF) and TMED (T. Rowe Price Health Care ETF) are both exchange-traded funds - RCLY is a Actively Managed fund actively managed by Reckoner, while TMED is a Health & Biotech Equities fund actively managed by T. Rowe Price. Both are actively managed. Their 0.01 correlation means their historical movements had little consistent relationship. RCLY charges 0.55%/yr vs 0.44%/yr for TMED.
Performance
RCLY vs. TMED - Performance Comparison
Loading charts...
Returns By Period
RCLY
- 1D
- 0.00%
- 1M
- 0.33%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
TMED
- 1D
- -0.74%
- 1M
- 1.35%
- 6M
- 16.95%
- YTD
- 16.91%
- 1Y
- 42.30%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 34.49%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $608.53 | $622.30 | $3.07K | |
| $576.43K | $346.09K | $158.73K |
RCLY vs. TMED - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
RCLY Reckoner BBB-B CLO Annual ETF | 1.40% |
TMED T. Rowe Price Health Care ETF | 18.27% |
Correlation
The correlation between RCLY and TMED is 0.01, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Feb 11, 2026 | 0.01 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RCLY vs. TMED — Risk / Return Rank
RCLY
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
TMED
RCLY vs. TMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Reckoner BBB-B CLO Annual ETF (RCLY) and T. Rowe Price Health Care ETF (TMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RCLY | TMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.40 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 3.83 | — |
| Martin ratioReturn relative to average drawdown | — | 13.07 | — |
Loading charts...
Drawdowns
RCLY vs. TMED - Drawdown Comparison
The maximum RCLY drawdown since its inception was -3.69%, smaller than the maximum TMED drawdown of -11.11%. Use the drawdown chart below to compare losses from any high point for RCLY and TMED.
Loading charts...
Drawdown Indicators
| RCLY | TMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -3.69% | -11.11% | +7.42% |
Max Drawdown (1Y)Largest decline over 1 year | — | -11.11% | — |
Current DrawdownCurrent decline from peak | 0.00% | -1.80% | +1.80% |
Average DrawdownAverage peak-to-trough decline | -0.68% | -2.41% | +1.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.25% | — |
Volatility
RCLY vs. TMED - Volatility Comparison
Loading charts...
Volatility by Period
| RCLY | TMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 4.97% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 14.01% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 3.46% | 18.35% | -14.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 3.46% | 18.11% | -14.65% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 3.46% | 18.11% | -14.65% |
RCLY vs. TMED - Expense Ratio Comparison
RCLY has a 0.55% expense ratio, which is higher than TMED's 0.44% expense ratio.
Dividends
RCLY vs. TMED - Dividend Comparison
RCLY has not paid dividends to shareholders, while TMED's dividend yield for the trailing twelve months is around 0.47%.
| Position | TTM | 2025 |
|---|---|---|
RCLY Reckoner BBB-B CLO Annual ETF | 0.00% | 0.00% |
TMED T. Rowe Price Health Care ETF | 0.47% | 0.54% |
Frequently Asked Questions
RCLY and TMED have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TMED is cheaper with a 0.44% expense ratio, compared with 0.55% for RCLY.
TMED has the higher dividend yield at 0.47%, compared with 0.00% for RCLY.
RCLY is categorized as Actively Managed, while TMED is Health & Biotech Equities. They also come from different issuers: Reckoner and T. Rowe Price. Their fees differ too: 0.55% for RCLY and 0.44% for TMED.
Find the right allocation for RCLY and TMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer